NM_013378 |
VPREB3 |
pre-B lymphocyte 3 |
chr22q11.23|22q11 |
0.784744031 |
0 |
220068_at |
21.58091091 |
3.08E-31 |
16 / 12428 |
MSPI0406S00960076 |
3.72194939 |
2.98E-87 |
NM_001114094 |
BLNK |
B-cell linker |
chr10q23.2-q23.33 |
0.741619233 |
0 |
207655_s_at |
14.40439696 |
5.27E-35 |
5 / 12428 |
MSPI0406S00529872 |
3.648877061 |
6.12E-55 |
NM_003877 |
SOCS2 |
suppressor of cytokine signaling 2 |
chr12q |
0.722262065 |
0 |
203373_at |
8.924202252 |
3.23E-17 |
113 / 12428 |
MSPI0406S00622030 |
0.898731451 |
1.68E-08 |
NM_000626 |
CD79B |
CD79b molecule, immunoglobulin-associated beta |
chr17q23 |
0.696507731 |
0 |
205297_s_at |
7.499343274 |
3.17E-32 |
13 / 12428 |
MSPI0406S00819368 |
3.315305812 |
1.13E-24 |
NM_001017520 |
DNTT |
deoxynucleotidyltransferase, terminal |
chr10q23-q24 |
0.696389401 |
0 |
210487_at |
3.371135806 |
4.00E-05 |
924 / 12428 |
MSPI0406S00529880 |
0.734732878 |
0.00385653 |
NM_001025158 |
CD74 |
CD74 molecule, major histocompatibility complex, class II invariant chain |
chr5q32 |
0.695086285 |
0 |
209619_at |
10.50124539 |
7.15E-38 |
3 / 12428 |
MSPI0406S00290338 |
1.888909544 |
1.21E-33 |
NM_024330 |
SLC27A3 |
solute carrier family 27 (fatty acid transporter), member 3 |
chr1q21.3 |
0.684481612 |
0 |
222217_s_at |
4.402158175 |
3.23E-17 |
112 / 12428 |
MSPI0406S00056272 |
2.689051171 |
5.29E-46 |
NM_002123 |
HLA-DQB1 |
major histocompatibility complex, class II, DQ beta 1 |
chr6p21.3 |
0.68052751 |
0 |
209480_at |
3.898817535 |
5.72E-06 |
748 / 12428 |
MSPI0406S00316874 |
0.536347212 |
0.022230953 |
NM_001783 |
CD79A |
CD79a molecule, immunoglobulin-associated alpha |
chr19q13.2 |
0.654445666 |
0 |
205049_s_at |
5.59779464 |
3.10E-29 |
24 / 12428 |
MSPI0406S00894273 |
1.751754074 |
1.10E-28 |
NM_002039 |
GAB1 |
GRB2-associated binding protein 1 |
chr4q31.21 |
0.648497584 |
0 |
207112_s_at |
4.661966847 |
1.18E-16 |
123 / 12428 |
MSPI0406S00245299 |
2.520172194 |
1.99E-10 |
NM_002201 |
ISG20 |
interferon stimulated exonuclease gene 20kDa |
chr15q26 |
0.613283951 |
0 |
33304_at |
2.54717525 |
4.37E-10 |
345 / 12428 |
MSPI0406S00726380 |
1.456329126 |
2.34E-09 |
NM_001142370 |
PTPN18 |
protein tyrosine phosphatase, non-receptor type 18 (brain-derived) |
chr2q21.1 |
0.612368077 |
0 |
213521_at |
2.088021416 |
1.82E-10 |
324 / 12428 |
MSPI0406S00131861 |
2.566920974 |
2.73E-24 |
NM_003263 |
TLR1 |
toll-like receptor 1 |
chr4p14 |
0.610836388 |
0 |
210176_at |
1.815906944 |
2.38E-07 |
565 / 12428 |
MSPI0406S00228209 |
2.677105489 |
3.26E-19 |
NM_002217 |
ITIH3 |
inter-alpha (globulin) inhibitor H3 |
chr3p21.2-p21.1 |
0.59477056 |
4.44E-16 |
205755_at |
2.30119708 |
1.94E-06 |
669 / 12428 |
MSPI0406S00180110 |
2.653303247 |
1.10E-20 |
NM_001803 |
CD52 |
CD52 molecule |
chr1p36 |
0.593929444 |
4.44E-16 |
34210_at |
2.949810675 |
1.67E-08 |
449 / 12428 |
MSPI0406S00022814 |
2.065061693 |
7.53E-23 |
NM_001142286 |
SMC6 |
structural maintenance of chromosomes 6 |
chr2p24.2 |
0.579537436 |
3.33E-15 |
218781_at |
1.872165845 |
1.67E-08 |
450 / 12428 |
MSPI0406S00095781 |
1.766062963 |
1.31E-18 |
NM_019086 |
FLJ20674 |
hypothetical protein FLJ20674 |
chr12q24.23 |
0.578116797 |
4.22E-15 |
220137_at |
2.012106134 |
1.30E-12 |
223 / 12428 |
MSPI0406S00632198 |
3.289319642 |
3.98E-72 |
NM_022081 |
HPS4 |
Hermansky-Pudlak syndrome 4 |
chr22cen-q12.3 |
0.57113896 |
1.04E-14 |
218402_s_at |
1.962425338 |
4.81E-05 |
943 / 12428 |
MSPI0406S00962017 |
0.921590848 |
0.001085247 |
NM_003730 |
RNASET2 |
ribonuclease T2 |
chr6q27 |
0.550593069 |
1.39E-13 |
217984_at |
2.266749069 |
1.12E-08 |
434 / 12428 |
MSPI0406S00349065 |
1.485415804 |
3.01E-25 |
NM_001470 |
GABBR1 |
gamma-aminobutyric acid (GABA) B receptor, 1 |
chr6p21.31 |
0.540349127 |
4.73E-13 |
203146_s_at |
1.667080973 |
0.001177748 |
1412 / 12428 |
MSPI0406S00314790 |
2.720633096 |
2.95E-19 |
NM_001135585 |
SLC2A5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
chr1p36.2 |
0.532818145 |
1.14E-12 |
204430_s_at |
5.337941456 |
1.66E-11 |
262 / 12428 |
MSPI0406S00008592 |
0.580425563 |
0.007133431 |
NM_001769 |
CD9 |
CD9 molecule |
chr12p13.3 |
0.532074144 |
1.24E-12 |
201005_at |
13.66445993 |
2.06E-14 |
165 / 12428 |
MSPI0406S00600155 |
1.399029714 |
5.77E-14 |
NM_015150 |
RFTN1 |
raftlin, lipid raft linker 1 |
chr3p25.1-p24.3 |
0.530890918 |
1.42E-12 |
212646_at |
2.230987585 |
1.86E-11 |
263 / 12428 |
MSPI0406S00168555 |
1.213164129 |
2.71E-05 |
NM_001164281 |
TRAF3IP2 |
TRAF3 interacting protein 2 |
chr6q21 |
0.520550642 |
4.52E-12 |
215411_s_at |
3.591145986 |
6.06E-16 |
131 / 12428 |
MSPI0406S00334940 |
1.664419592 |
1.61E-33 |
NM_007128 |
VPREB1 |
pre-B lymphocyte 1 |
chr22q11.2|22q11.22 |
0.515935354 |
7.49E-12 |
221349_at |
12.64347429 |
3.83E-21 |
79 / 12428 |
MSPI0406S00959025 |
0.277750747 |
0.014992945 |
NM_033554 |
HLA-DPA1 |
major histocompatibility complex, class II, DP alpha 1 |
chr6p21.3 |
0.513910841 |
9.33E-12 |
211991_s_at |
14.99204043 |
6.00E-30 |
20 / 12428 |
MSPI0406S00317006 |
1.136498301 |
2.27E-08 |
NM_014674 |
EDEM1 |
ER degradation enhancer, mannosidase alpha-like 1 |
chr3p26.1 |
0.513697371 |
9.55E-12 |
203279_at |
1.79169918 |
4.47E-06 |
725 / 12428 |
MSPI0406S00163315 |
2.602567677 |
2.39E-44 |
NM_002121 |
HLA-DPB1 |
major histocompatibility complex, class II, DP beta 1 |
chr6p21.3 |
0.504542551 |
2.53E-11 |
201137_s_at |
9.318840032 |
3.17E-28 |
27 / 12428 |
MSPI0406S00317006 |
1.136498301 |
2.27E-08 |
NM_006504 |
PTPRE |
protein tyrosine phosphatase, receptor type, E |
chr10q26 |
0.503544419 |
2.81E-11 |
221840_at |
3.666063486 |
1.35E-19 |
86 / 12428 |
MSPI0406S00543311 |
1.829923956 |
1.21E-21 |
NM_004711 |
SYNGR1 |
synaptogyrin 1 |
chr22q13.1 |
0.499778505 |
4.15E-11 |
213854_at |
2.496392755 |
3.82E-11 |
271 / 12428 |
MSPI0406S00971311 |
2.003718168 |
5.63E-13 |
NM_001771 |
CD22 |
CD22 molecule |
chr19q13.1 |
0.494653514 |
7.01E-11 |
38521_at |
4.529786089 |
1.69E-26 |
34 / 12428 |
MSPI0406S00888496 |
2.340081911 |
3.46E-15 |
NM_004414 |
RCAN1 |
regulator of calcineurin 1 |
chr21q22.1-q22.2|21q22.12 |
0.494471313 |
7.14E-11 |
208370_s_at |
3.44767046 |
4.91E-10 |
347 / 12428 |
MSPI0406S00945298 |
0.932576112 |
2.72E-07 |
NM_005026 |
PIK3CD |
phosphoinositide-3-kinase, catalytic, delta polypeptide |
chr1p36.2 |
0.493404014 |
7.95E-11 |
203879_at |
2.216301787 |
2.07E-13 |
190 / 12428 |
MSPI0406S00009266 |
1.227183354 |
4.63E-16 |
NM_002117 |
HLA-C |
major histocompatibility complex, class I, C |
chr6p21.3 |
0.491009602 |
1.01E-10 |
214459_x_at |
1.827492281 |
2.50E-07 |
568 / 12428 |
MSPI0406S00315789 |
1.178747598 |
5.72E-07 |
NM_006235 |
POU2AF1 |
POU class 2 associating factor 1 |
chr11q23.1 |
0.488411537 |
1.31E-10 |
205267_at |
6.293545876 |
2.04E-23 |
63 / 12428 |
MSPI0406S00585713 |
1.684062159 |
3.72E-09 |
NM_021182 |
HMHB1 |
histocompatibility (minor) HB-1 |
chr5q31.3 |
0.487558037 |
1.43E-10 |
208302_at |
1.938261169 |
5.90E-10 |
353 / 12428 |
MSPI0406S00288561 |
2.905400037 |
2.84E-77 |
NM_001006109 |
C3orf37 |
Chromosome 3 open reading frame 37 |
chr3q21.3 |
0.484495436 |
1.93E-10 |
201678_s_at |
1.579840986 |
8.81E-07 |
629 / 12428 |
MSPI0406S00196352 |
1.584511042 |
2.49E-36 |
NM_005230 |
ELK3 |
ELK3, ETS-domain protein (SRF accessory protein 2) |
chr12q23 |
0.484039038 |
2.02E-10 |
206127_at |
2.471533733 |
4.24E-08 |
488 / 12428 |
MSPI0406S00623057 |
1.026020384 |
4.40E-16 |
NM_016215 |
EGFL7 |
EGF-like-domain, multiple 7 |
chr9q34.3 |
0.477634679 |
3.76E-10 |
218825_at |
2.713595236 |
2.65E-05 |
872 / 12428 |
MSPI0406S00494995 |
1.382168326 |
1.23E-19 |
NM_014430 |
CIDEB |
cell death-inducing DFFA-like effector b |
chr14q12 |
0.468928578 |
8.58E-10 |
221188_s_at |
1.484611774 |
0.001938375 |
1517 / 12428 |
MSPI0406S00669634 |
3.018915574 |
1.31E-38 |
NM_001560 |
IL13RA1 |
interleukin 13 receptor, alpha 1 |
chrXq24 |
0.46598853 |
1.13E-09 |
201887_at |
1.752615547 |
0.000774975 |
1332 / 12428 |
MSPI0406S01010806 |
0.77358999 |
0.005574155 |
NM_000476 |
AK1 |
adenylate kinase 1 |
chr9q34.1 |
0.465524819 |
1.18E-09 |
202587_s_at |
2.436292247 |
2.84E-12 |
236 / 12428 |
MSPI0406S00484960 |
1.301273998 |
5.99E-09 |
NM_006747 |
SIPA1 |
signal-induced proliferation-associated 1 |
chr11q13 |
0.458798887 |
2.18E-09 |
204164_at |
2.312700512 |
1.58E-11 |
261 / 12428 |
MSPI0406S00570952 |
0.993453368 |
1.14E-09 |
NM_007079 |
PTP4A3 |
protein tyrosine phosphatase type IVA, member 3 |
chr8q24.3 |
0.456493438 |
2.68E-09 |
209695_at |
1.577397571 |
0.000528141 |
1258 / 12428 |
MSPI0406S00447631 |
0.677378852 |
1.83E-06 |
NM_004425 |
ECM1 |
extracellular matrix protein 1 |
chr1q21 |
0.455866176 |
2.83E-09 |
209365_s_at |
3.101432141 |
6.44E-07 |
618 / 12428 |
MSPI0406S00054603 |
1.345973208 |
2.49E-10 |
NM_001782 |
CD72 |
CD72 molecule |
chr9p13.3 |
0.453365179 |
3.54E-09 |
215925_s_at |
7.168070111 |
7.18E-21 |
80 / 12428 |
MSPI0406S00459439 |
0.779567144 |
3.40E-11 |
NM_005582 |
CD180 |
CD180 molecule |
chr5q12 |
0.45124868 |
4.27E-09 |
206206_at |
1.904759813 |
0.000204397 |
1101 / 12428 |
MSPI0406S00271573 |
0.577437862 |
0.030382834 |
NM_004119 |
FLT3 |
fms-related tyrosine kinase 3 |
chr13q12 |
0.451111966 |
4.32E-09 |
206674_at |
3.675921243 |
5.55E-08 |
499 / 12428 |
MSPI0406S00647380 |
0.546198162 |
0.006164801 |
NM_031409 |
CCR6 |
chemokine (C-C motif) receptor 6 |
chr6q27 |
0.450420232 |
4.59E-09 |
206983_at |
1.557111185 |
0.006013574 |
1876 / 12428 |
MSPI0406S00349145 |
2.961493542 |
1.26E-16 |
NM_001160 |
APAF1 |
apoptotic peptidase activating factor 1 |
chr12q23 |
0.442088665 |
9.47E-09 |
204859_s_at |
1.261033893 |
0.026513077 |
2547 / 12428 |
MSPI0406S00623620 |
1.009079157 |
4.49E-05 |
NM_002122 |
HLA-DQA1 |
major histocompatibility complex, class II, DQ alpha 1 |
chr6p21.3 |
0.440401304 |
1.09E-08 |
212671_s_at |
8.780543724 |
1.12E-16 |
122 / 12428 |
MSPI0406S00316861 |
0.813526076 |
0.011660571 |
NM_002397 |
MEF2C |
myocyte enhancer factor 2C |
chr5q14 |
0.438577854 |
1.28E-08 |
209200_at |
17.46850548 |
3.80E-26 |
40 / 12428 |
MSPI0406S00276770 |
1.027288188 |
0.000964669 |
NM_001025160 |
CD97 |
CD97 molecule |
chr19p13 |
0.437354566 |
1.42E-08 |
202910_s_at |
1.480060623 |
0.030567257 |
2626 / 12428 |
MSPI0406S00875960 |
1.00521792 |
1.63E-15 |
NM_004479 |
FUT7 |
fucosyltransferase 7 (alpha (1,3) fucosyltransferase) |
chr9q34.3 |
0.433440129 |
1.97E-08 |
210506_at |
1.580262278 |
0.044210313 |
2875 / 12428 |
MSPI0406S00495547 |
0.729978847 |
9.98E-07 |
NM_005775 |
SORBS3 |
sorbin and SH3 domain containing 3 |
chr8p21.3 |
0.430261994 |
2.56E-08 |
209253_at |
2.401618486 |
2.70E-12 |
234 / 12428 |
MSPI0406S00418578 |
0.781098976 |
2.45E-06 |
NM_005514 |
HLA-B |
major histocompatibility complex, class I, B |
chr6p21.3 |
0.426778008 |
3.40E-08 |
208729_x_at |
2.295880989 |
1.38E-09 |
375 / 12428 |
MSPI0406S00315809 |
0.372968125 |
0.008585087 |
NM_001142523 |
IRAK3 |
interleukin-1 receptor-associated kinase 3 |
chr12q14.3 |
0.42486291 |
3.98E-08 |
213817_at |
3.473094719 |
2.72E-08 |
466 / 12428 |
MSPI0406S00618117 |
1.180283661 |
1.74E-06 |
NM_004157 |
PRKAR2A |
protein kinase, cAMP-dependent, regulatory, type II, alpha |
chr3p21.3-p21.2 |
0.422596724 |
4.77E-08 |
213052_at |
1.254447692 |
1.26E-05 |
815 / 12428 |
MSPI0406S00177107 |
1.616787157 |
1.21E-23 |
NM_012408 |
ZMYND8 |
zinc finger, MYND-type containing 8 |
chr20q13.12 |
0.422113943 |
4.96E-08 |
209048_s_at |
1.668514806 |
3.60E-10 |
341 / 12428 |
MSPI0406S00927996 |
2.755167751 |
8.65E-24 |
NM_004050 |
BCL2L2 |
BCL2-like 2 |
chr14q11.2-q12 |
0.419067344 |
6.33E-08 |
209311_at |
1.410115048 |
7.06E-06 |
766 / 12428 |
MSPI0406S00668977 |
1.738418388 |
1.08E-14 |
NM_001068 |
TOP2B |
topoisomerase (DNA) II beta 180kDa |
chr3p24 |
0.417002381 |
7.46E-08 |
211987_at |
1.950943375 |
3.06E-14 |
170 / 12428 |
MSPI0406S00169952 |
2.387906031 |
1.11E-32 |
NM_001715 |
BLK |
B lymphoid tyrosine kinase |
chr8p23-p22 |
0.414471248 |
9.10E-08 |
206255_at |
2.109188532 |
0.002629849 |
1588 / 12428 |
MSPI0406S00414852 |
0.788876235 |
1.56E-11 |
NM_000061 |
BTK |
Bruton agammaglobulinemia tyrosine kinase |
chrXq21.33-q22 |
0.41107636 |
1.19E-07 |
205504_at |
4.475938738 |
1.03E-29 |
21 / 12428 |
MSPI0406S01007568 |
1.255027494 |
6.17E-06 |
NM_006271 |
S100A1 |
S100 calcium binding protein A1 |
chr1q21 |
0.408607289 |
1.43E-07 |
205334_at |
2.118657985 |
6.02E-06 |
755 / 12428 |
MSPI0406S00056135 |
2.014189314 |
8.16E-13 |
NM_014146 |
LAT2 |
linker for activation of T cells family, member 2 |
chr7q11.23 |
0.407130693 |
1.61E-07 |
221581_s_at |
5.738092836 |
8.34E-18 |
99 / 12428 |
MSPI0406S00379603 |
1.18950007 |
1.29E-14 |
NM_213602 |
SIGLEC15 |
sialic acid binding Ig-like lectin 15 |
chr18q12.3 |
0.405870554 |
1.77E-07 |
215856_at |
1.568115495 |
0.021448509 |
2412 / 12428 |
MSPI0406S00847655 |
1.807107215 |
1.95E-15 |
NM_001024372 |
BAALC |
brain and acute leukemia, cytoplasmic |
chr8q22.3 |
0.402751627 |
2.24E-07 |
218899_s_at |
1.706585148 |
0.036387674 |
2735 / 12428 |
MSPI0406S00438806 |
1.192316543 |
4.02E-06 |
NM_001024211 |
S100A13 |
S100 calcium binding protein A13 |
chr1q21 |
0.400761323 |
2.60E-07 |
202598_at |
2.15828154 |
4.17E-12 |
243 / 12428 |
MSPI0406S00056131 |
1.1608425 |
0.001301415 |
NM_013258 |
PYCARD |
PYD and CARD domain containing |
chr16p12-p11.2 |
0.400625459 |
2.63E-07 |
221666_s_at |
1.433343262 |
0.015372365 |
2252 / 12428 |
MSPI0406S00755614 |
0.949068844 |
2.00E-12 |
NM_007271 |
STK38 |
serine/threonine kinase 38 |
chr6p21 |
0.39844181 |
3.09E-07 |
202951_at |
1.923749384 |
9.88E-09 |
430 / 12428 |
MSPI0406S00319698 |
1.787814448 |
5.58E-15 |
NM_005605 |
PPP3CC |
protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform |
chr8p21.3 |
0.393950237 |
4.31E-07 |
207000_s_at |
3.881409031 |
1.37E-23 |
59 / 12428 |
MSPI0406S00418534 |
1.358714996 |
5.12E-11 |
NM_015147 |
CEP68 |
centrosomal protein 68kDa |
chr2p14 |
0.393946044 |
4.31E-07 |
207971_s_at |
1.523008786 |
6.25E-05 |
980 / 12428 |
MSPI0406S00110875 |
1.017346752 |
1.20E-17 |
NM_001945 |
HBEGF |
heparin-binding EGF-like growth factor |
chr5q23 |
0.392576338 |
4.76E-07 |
203821_at |
3.020696025 |
0.0001073 |
1031 / 12428 |
MSPI0406S00286985 |
3.283937139 |
3.66E-19 |
NM_001143919 |
LTB4R |
leukotriene B4 receptor |
chr14q11.2-q12 |
0.392251603 |
4.87E-07 |
210128_s_at |
1.874522552 |
3.08E-07 |
580 / 12428 |
MSPI0406S00669634 |
3.018915574 |
1.31E-38 |
NM_002649 |
PIK3CG |
phosphoinositide-3-kinase, catalytic, gamma polypeptide |
chr7q22.3 |
0.390064865 |
5.71E-07 |
206369_s_at |
2.865061406 |
1.52E-10 |
317 / 12428 |
MSPI0406S00391334 |
1.391994553 |
1.64E-07 |
NM_003262 |
SEC62 |
SEC62 homolog (S. cerevisiae) |
chr3q26.2 |
0.389674624 |
5.88E-07 |
208942_s_at |
1.174956457 |
0.034989511 |
2720 / 12428 |
MSPI0406S00204488 |
2.35428282 |
1.16E-16 |
NM_001135191 |
ASAP2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
chr2p25|2p24 |
0.38837741 |
6.45E-07 |
206414_s_at |
1.703379367 |
0.003741589 |
1697 / 12428 |
MSPI0406S00092398 |
1.206167076 |
9.82E-09 |
NM_020070 |
IGLL1 |
immunoglobulin lambda-like polypeptide 1 |
chr22q11.23 |
0.38808208 |
6.59E-07 |
206660_at |
2.610574287 |
0.003057996 |
1636 / 12428 |
MSPI0406S00959914 |
0.423224432 |
1.42E-07 |
NM_001114618 |
MGAT1 |
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
chr5q35 |
0.384701429 |
8.39E-07 |
201126_s_at |
1.525530592 |
7.09E-07 |
625 / 12428 |
MSPI0406S00302928 |
1.143800945 |
7.24E-25 |
NM_024490 |
ATP10A |
ATPase, class V, type 10A |
chr15q11.2 |
0.382751277 |
9.63E-07 |
214255_at |
1.59806748 |
0.014398167 |
2212 / 12428 |
MSPI0406S00700799 |
1.267126035 |
6.67E-05 |
NM_023015 |
INTS3 |
integrator complex subunit 3 |
chr1q21.3 |
0.381436255 |
1.06E-06 |
202809_s_at |
1.813676436 |
3.10E-06 |
702 / 12428 |
MSPI0406S00056245 |
0.886212724 |
3.39E-14 |
NM_014959 |
CARD8 |
caspase recruitment domain family, member 8 |
chr19q13.33 |
0.377982971 |
1.35E-06 |
204950_at |
1.380491839 |
0.001206511 |
1418 / 12428 |
MSPI0406S00900053 |
0.773995765 |
0.000165481 |
NM_001236 |
CBR3 |
carbonyl reductase 3 |
chr21q22.2 |
0.376925754 |
1.45E-06 |
205379_at |
2.11304127 |
0.000162991 |
1071 / 12428 |
MSPI0406S00945832 |
1.291893938 |
7.26E-14 |
NM_000048 |
ASL /// CRCP |
argininosuccinate lyase /// CGRP receptor component |
chr7cen-q11.2 /// chr7q11.21 |
0.374362047 |
1.73E-06 |
204608_at |
1.492662423 |
0.000104703 |
1029 / 12428 |
MSPI0406S00374760 |
1.44668473 |
1.65E-17 |
NM_013233 |
STK39 |
serine threonine kinase 39 (STE20/SPS1 homolog, yeast) |
chr2q24.3 |
0.371662408 |
2.08E-06 |
202786_at |
1.438391324 |
0.026352009 |
2542 / 12428 |
MSPI0406S00138625 |
0.549549834 |
0.000169237 |
NM_004840 |
ARHGEF6 |
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
chrXq26.3 |
0.369650072 |
2.38E-06 |
209539_at |
1.25044494 |
0.04718179 |
2935 / 12428 |
MSPI0406S01015291 |
0.634560965 |
0.01086548 |
NM_024734 |
CLMN |
calmin (calponin-like, transmembrane) |
chr14q32.13 |
0.368628494 |
2.55E-06 |
213839_at |
1.514339651 |
0.026937916 |
2552 / 12428 |
MSPI0406S00689865 |
0.827668936 |
7.03E-10 |
NM_016021 |
UBE2J1 |
ubiquitin-conjugating enzyme E2, J1 (UBC6 homolog, yeast) |
chr6q15 |
0.367782621 |
2.70E-06 |
217823_s_at |
1.672067415 |
3.85E-05 |
916 / 12428 |
MSPI0406S00330769 |
1.853753739 |
7.36E-12 |
NM_033386 |
MICALL1 |
MICAL-like 1 |
chr22q13.1-q13.2 |
0.364296428 |
3.41E-06 |
55081_at |
1.42467043 |
6.43E-07 |
617 / 12428 |
MSPI0406S00969697 |
2.326604451 |
1.10E-21 |
NM_014666 |
CLINT1 |
clathrin interactor 1 |
chr5q33.3 |
0.361004772 |
4.23E-06 |
201768_s_at |
1.175180405 |
0.046612975 |
2922 / 12428 |
MSPI0406S00292577 |
1.612916574 |
4.41E-12 |
NM_002452 |
NUDT1 |
nudix (nucleoside diphosphate linked moiety X)-type motif 1 |
chr7p22 |
0.36090026 |
4.26E-06 |
204766_s_at |
1.554890388 |
0.016130463 |
2280 / 12428 |
MSPI0406S00354667 |
1.051100579 |
1.58E-13 |
NM_015015 |
KDM4B |
lysine (K)-specific demethylase 4B |
chr19p13.3 |
0.354720907 |
6.37E-06 |
212496_s_at |
1.792617037 |
1.07E-05 |
802 / 12428 |
MSPI0406S00865599 |
0.615375187 |
0.048242097 |
NM_000118 |
ENG |
endoglin |
chr9q33-q34.1 |
0.349033846 |
9.15E-06 |
201809_s_at |
3.159064487 |
6.76E-11 |
292 / 12428 |
MSPI0406S00484935 |
1.023697398 |
5.72E-07 |
NM_003583 |
DYRK2 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
chr12q15 |
0.346488648 |
1.07E-05 |
202969_at |
1.640940988 |
8.34E-08 |
516 / 12428 |
MSPI0406S00618333 |
1.362966565 |
6.62E-24 |
NM_018656 |
SLC35E3 |
solute carrier family 35, member E3 |
chr12q15 |
0.345394494 |
1.15E-05 |
218988_at |
5.701815729 |
3.00E-11 |
268 / 12428 |
MSPI0406S00618596 |
0.356591823 |
3.71E-05 |
NM_020185 |
DUSP22 |
dual specificity phosphatase 22 |
chr6p25.3 |
0.345121679 |
1.17E-05 |
218845_at |
1.601469664 |
3.33E-08 |
480 / 12428 |
MSPI0406S00303444 |
1.50916082 |
4.23E-15 |
NM_001076787 |
TP53I11 |
tumor protein p53 inducible protein 11 |
chr11p11.2 |
0.344712073 |
1.20E-05 |
214667_s_at |
1.726590916 |
0.004701088 |
1784 / 12428 |
MSPI0406S00562232 |
2.859652999 |
2.03E-26 |
NM_002800 |
PSMB9 |
proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2) |
chr6p21.3 |
0.342306969 |
1.39E-05 |
204279_at |
1.4764489 |
0.000942425 |
1373 / 12428 |
MSPI0406S00316938 |
0.726509549 |
0.037716302 |
NM_025159 |
CXorf21 |
chromosome X open reading frame 21 |
chrXp21.2 |
0.342182393 |
1.40E-05 |
220252_x_at |
2.011897067 |
9.63E-06 |
794 / 12428 |
MSPI0406S00992365 |
1.534516056 |
4.26E-20 |
NM_002287 |
LAIR1 |
leukocyte-associated immunoglobulin-like receptor 1 |
chr19q13.4 |
0.339182859 |
1.68E-05 |
210644_s_at |
1.484640091 |
0.004355335 |
1757 / 12428 |
MSPI0406S00906287 |
1.250865607 |
1.61E-08 |
NM_004288 |
CYTIP |
cytohesin 1 interacting protein |
chr2q11.2 |
0.338822375 |
1.72E-05 |
209606_at |
1.769341119 |
0.000206778 |
1103 / 12428 |
MSPI0406S00136981 |
1.164641691 |
5.36E-11 |
NM_004232 |
SOCS6 |
suppressor of cytokine signaling 6 |
chr18q22.2 |
0.330677506 |
2.81E-05 |
206020_at |
1.364480778 |
0.020571994 |
2392 / 12428 |
MSPI0406S00854096 |
0.677252424 |
0.000321145 |
NM_000246 |
CIITA |
class II, major histocompatibility complex, transactivator |
chr16p13 |
0.330129555 |
2.90E-05 |
205101_at |
7.066132001 |
1.37E-33 |
9 / 12428 |
MSPI0406S00742469 |
0.962212668 |
1.31E-05 |
NM_005100 |
AKAP12 |
A kinase (PRKA) anchor protein 12 |
chr6q24-q25 |
0.329505144 |
3.01E-05 |
210517_s_at |
4.550956372 |
2.04E-07 |
555 / 12428 |
MSPI0406S00342872 |
0.703003249 |
1.68E-10 |
NM_001946 |
DUSP6 |
dual specificity phosphatase 6 |
chr12q22-q23 |
0.328323572 |
3.22E-05 |
208892_s_at |
2.392691377 |
1.39E-06 |
651 / 12428 |
MSPI0406S00621301 |
0.77929829 |
2.71E-10 |
NM_016121 |
KCTD3 |
potassium channel tetramerisation domain containing 3 |
chr1q41 |
0.326890095 |
3.51E-05 |
217894_at |
1.739581225 |
2.46E-05 |
861 / 12428 |
MSPI0406S00074548 |
0.737598671 |
0.000468043 |
NM_003307 |
TRPM2 |
transient receptor potential cation channel, subfamily M, member 2 |
chr21q22.3 |
0.324507288 |
4.03E-05 |
205708_s_at |
1.626474849 |
0.00019485 |
1092 / 12428 |
MSPI0406S00951558 |
1.39603692 |
4.92E-13 |
NM_005574 |
LMO2 |
LIM domain only 2 (rhombotin-like 1) |
chr11p13 |
0.322680056 |
4.48E-05 |
204249_s_at |
1.520808558 |
0.009296691 |
2027 / 12428 |
MSPI0406S00559727 |
0.480361691 |
0.009957542 |
NM_025113 |
C13orf18 |
chromosome 13 open reading frame 18 |
chr13q14.13 |
0.318613716 |
5.65E-05 |
44790_s_at |
2.391793334 |
0.000712026 |
1314 / 12428 |
MSPI0406S00652217 |
0.780862268 |
4.35E-12 |
NM_005907 |
MAN1A1 |
mannosidase, alpha, class 1A, member 1 |
chr6q22 |
0.316924151 |
6.21E-05 |
221760_at |
2.985032583 |
2.90E-05 |
881 / 12428 |
MSPI0406S00336211 |
0.842920521 |
7.69E-06 |
NM_000389 |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
chr6p21.2 |
0.313899496 |
7.36E-05 |
202284_s_at |
4.806850531 |
4.12E-15 |
145 / 12428 |
MSPI0406S00319805 |
0.51023796 |
0.003676786 |
NM_014795 |
ZEB2 |
zinc finger E-box binding homeobox 2 |
chr2q22.3 |
0.310400018 |
8.94E-05 |
203603_s_at |
2.873298801 |
3.26E-16 |
130 / 12428 |
MSPI0406S00135007 |
0.7129151 |
5.58E-06 |
NM_006932 |
SMTN |
smoothelin |
chr22q12.2 |
0.308953214 |
9.68E-05 |
207390_s_at |
1.765409708 |
0.00071505 |
1318 / 12428 |
MSPI0406S00964990 |
1.492592204 |
8.18E-30 |
NM_000581 |
GPX1 |
glutathione peroxidase 1 |
chr3p21.3 |
0.307907171 |
0.000102454 |
200736_s_at |
2.270121286 |
3.05E-10 |
335 / 12428 |
MSPI0406S00177627 |
0.354647735 |
0.017390421 |
NM_001024808 |
BCL7A |
B-cell CLL/lymphoma 7A |
chr12q24.13 |
0.306139746 |
0.0001128 |
203795_s_at |
1.401908198 |
0.015273881 |
2246 / 12428 |
MSPI0406S00634978 |
0.724395988 |
1.24E-05 |
NM_001013694 |
SRRD |
SRR1 domain containing |
chr22q12.1 |
0.301101333 |
0.000147898 |
213608_s_at |
1.391878927 |
0.006635509 |
1909 / 12428 |
MSPI0406S00962017 |
0.921590848 |
0.001085247 |
NM_000101 |
CYBA |
cytochrome b-245, alpha polypeptide |
chr16q24 |
0.28890605 |
0.000279254 |
203028_s_at |
1.624432281 |
0.000395217 |
1212 / 12428 |
MSPI0406S00778836 |
0.24396684 |
0.022914455 |
NM_001321 |
CSRP2 |
cysteine and glycine-rich protein 2 |
chr12q21.1 |
0.286751616 |
0.000311528 |
207030_s_at |
7.98029658 |
5.00E-25 |
50 / 12428 |
MSPI0406S00619987 |
0.274788427 |
0.048862742 |
NM_153045 |
C9orf91 |
chromosome 9 open reading frame 91 |
chr9q32 |
0.286496115 |
0.000315576 |
221865_at |
1.396426365 |
1.82E-06 |
664 / 12428 |
MSPI0406S00479393 |
0.477025071 |
0.037400064 |
NM_001011667 |
CHCHD7 |
coiled-coil-helix-coiled-coil-helix domain containing 7 |
chr8q12.1 |
0.285072797 |
0.000339036 |
218642_s_at |
1.745599599 |
1.85E-07 |
548 / 12428 |
MSPI0406S00429545 |
0.499564444 |
1.64E-05 |
NM_005239 |
ETS2 |
v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) |
chr21q22.3|21q22.2 |
0.284230186 |
0.000353676 |
201328_at |
2.048849636 |
2.89E-05 |
879 / 12428 |
MSPI0406S00947260 |
0.503932744 |
0.013394919 |
NM_001134380 |
TBC1D5 |
TBC1 domain family, member 5 |
chr3p24.3 |
0.282191202 |
0.000391557 |
201813_s_at |
1.664165097 |
0.002951215 |
1620 / 12428 |
MSPI0406S00168751 |
0.335265377 |
0.02047252 |
NM_001005743 |
NUMB |
numb homolog (Drosophila) |
chr14q24.3 |
0.280855133 |
0.000418378 |
209073_s_at |
1.36676929 |
0.000201288 |
1095 / 12428 |
MSPI0406S00681677 |
1.268430511 |
7.36E-06 |
NM_000788 |
DCK |
deoxycytidine kinase |
chr4q13.3-q21.1 |
0.280738306 |
0.000420802 |
203302_at |
1.27141644 |
0.020557171 |
2390 / 12428 |
MSPI0406S00234064 |
1.070964167 |
2.42E-05 |
NM_001130480 |
VRK2 |
vaccinia related kinase 2 |
chr2p16-p15 |
0.28044082 |
0.000427034 |
205126_at |
1.416757484 |
3.10E-05 |
895 / 12428 |
MSPI0406S00108816 |
1.133484013 |
5.66E-06 |
NM_003693 |
SCARF1 |
scavenger receptor class F, member 1 |
chr17p13.3 |
0.279802362 |
0.000440698 |
206995_x_at |
1.650075363 |
5.39E-05 |
957 / 12428 |
MSPI0406S00782706 |
0.50745827 |
0.000569146 |
NM_004271 |
LY86 |
lymphocyte antigen 86 |
chr6p25.1 |
0.275432554 |
0.000545617 |
205859_at |
2.89985238 |
1.44E-12 |
224 / 12428 |
MSPI0406S00306424 |
0.745682061 |
2.16E-08 |
NM_000536 |
RAG2 |
recombination activating gene 2 |
chr11p13 |
0.274104719 |
0.000581795 |
215117_at |
1.616966282 |
0.026309218 |
2541 / 12428 |
MSPI0406S00560646 |
1.973682863 |
1.67E-08 |
NM_001115156 |
GDI2 |
GDP dissociation inhibitor 2 |
chr10p15 |
0.27378458 |
0.000590842 |
200009_at |
1.376976178 |
5.37E-05 |
956 / 12428 |
MSPI0406S00500320 |
0.638707581 |
2.39E-07 |
NM_001060 |
TBXA2R |
thromboxane A2 receptor |
chr19p13.3 |
0.268603277 |
0.000756501 |
336_at |
1.360612736 |
0.02852732 |
2591 / 12428 |
MSPI0406S00863537 |
0.628998813 |
9.59E-10 |
NM_001159291 |
MICAL1 |
microtubule associated monoxygenase, calponin and LIM domain containing 1 |
chr6q21 |
0.268186256 |
0.000771538 |
218376_s_at |
1.968154383 |
1.22E-05 |
813 / 12428 |
MSPI0406S00334252 |
0.339933617 |
0.000523945 |
NM_000129 |
F13A1 |
coagulation factor XIII, A1 polypeptide |
chr6p25.3-p24.3 |
0.268105667 |
0.000774475 |
203305_at |
2.265907851 |
8.61E-05 |
999 / 12428 |
MSPI0406S00306365 |
0.270630466 |
6.35E-05 |
NM_025076 |
UXS1 |
UDP-glucuronate decarboxylase 1 |
chr2q12.2 |
0.266526341 |
0.000834154 |
219675_s_at |
1.944698597 |
1.25E-14 |
157 / 12428 |
MSPI0406S00123125 |
0.653339274 |
7.65E-06 |
NM_019891 |
ERO1LB |
ERO1-like beta (S. cerevisiae) |
chr1q42.2-q43 |
0.266385916 |
0.000839659 |
220012_at |
1.918051497 |
1.11E-05 |
807 / 12428 |
MSPI0406S00082353 |
2.245745137 |
2.60E-28 |
NM_002567 |
PEBP1 |
phosphatidylethanolamine binding protein 1 |
chr12q24.23 |
0.263799723 |
0.000947213 |
210825_s_at |
1.674495856 |
8.62E-08 |
519 / 12428 |
MSPI0406S00632233 |
0.582505475 |
0.00101558 |
NM_002484 |
NUBP1 |
nucleotide binding protein 1 (MinD homolog, E. coli) |
chr16p13.13 |
0.262012099 |
0.001028788 |
203978_at |
1.520349159 |
2.93E-11 |
267 / 12428 |
MSPI0406S00742355 |
0.224757563 |
0.03252636 |
NM_016217 |
HECA |
headcase homolog (Drosophila) |
chr6q23-q24 |
0.260528651 |
0.001101317 |
218603_at |
1.435611762 |
0.00079339 |
1338 / 12428 |
MSPI0406S00339829 |
2.473367118 |
1.02E-24 |
NM_001031628 |
SMAGP |
small trans-membrane and glycosylated protein |
chr12q13.13 |
0.258984246 |
0.001181775 |
209679_s_at |
1.752648167 |
0.00323433 |
1653 / 12428 |
MSPI0406S00612442 |
0.882855263 |
0.00809589 |
NM_004568 |
SERPINB6 |
serpin peptidase inhibitor, clade B (ovalbumin), member 6 |
chr6p25 |
0.258574175 |
0.001204023 |
211474_s_at |
2.266737249 |
7.13E-07 |
626 / 12428 |
MSPI0406S00304760 |
0.636261579 |
4.99E-05 |
NM_004779 |
CNOT8 |
CCR4-NOT transcription complex, subunit 8 |
chr5q31-q33 |
0.257582449 |
0.001259422 |
202164_s_at |
1.203569921 |
0.015287712 |
2251 / 12428 |
MSPI0406S00291793 |
0.459680775 |
0.032533889 |
NM_006621 |
AHCYL1 |
adenosylhomocysteinase-like 1 |
chr1p13.2 |
0.257467741 |
0.001265978 |
200850_s_at |
1.163690775 |
0.026289365 |
2538 / 12428 |
MSPI0406S00049370 |
0.93694802 |
5.51E-08 |
NM_000252 |
MTM1 |
myotubularin 1 |
chrXq28 |
0.257302553 |
0.001275473 |
36920_at |
1.744369463 |
4.22E-06 |
718 / 12428 |
MSPI0406S01017993 |
1.666996297 |
1.34E-11 |
NM_015073 |
SIPA1L3 |
signal-induced proliferation-associated 1 like 3 |
chr19q13.13 |
0.256070594 |
0.00134837 |
213600_at |
1.631374054 |
0.000113847 |
1042 / 12428 |
MSPI0406S00890540 |
0.395536123 |
0.00868016 |
NM_001156474 |
CCDC81 |
coiled-coil domain containing 81 |
chr11q14.2 |
0.252975367 |
0.001548616 |
220389_at |
2.527969888 |
1.19E-05 |
809 / 12428 |
MSPI0406S00581723 |
1.314019403 |
2.18E-07 |
NM_004579 |
MAP4K2 |
mitogen-activated protein kinase kinase kinase kinase 2 |
chr11q13 |
0.251210311 |
0.001674596 |
204936_at |
1.392412861 |
0.023547733 |
2461 / 12428 |
MSPI0406S00569922 |
1.921360159 |
1.03E-43 |
NR_026779 |
C14orf139 |
chromosome 14 open reading frame 139 |
chr14q32.13 |
0.249337272 |
0.001818434 |
219563_at |
3.882360718 |
8.24E-23 |
69 / 12428 |
MSPI0406S00689927 |
0.837285497 |
0.00142176 |
NM_002116 |
HLA-A |
major histocompatibility complex, class I, A |
chr6p21.3 |
0.245563698 |
0.002142875 |
215313_x_at |
1.505219591 |
0.000119976 |
1046 / 12428 |
MSPI0406S00314925 |
0.599273749 |
0.003292916 |
NM_001664 |
RHOA |
ras homolog gene family, member A |
chr3p21.3 |
0.243693351 |
0.002322423 |
200059_s_at |
1.286814157 |
0.000971211 |
1384 / 12428 |
MSPI0406S00177688 |
0.716111045 |
4.56E-07 |
NM_006577 |
B3GNT2 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 |
chr2p15 |
0.241869838 |
0.002510499 |
219326_s_at |
1.456948814 |
0.001553378 |
1470 / 12428 |
MSPI0406S00110095 |
0.694769654 |
1.16E-07 |
NM_014240 |
LIMD1 |
LIM domains containing 1 |
chr3p21.3 |
0.241613155 |
0.002538053 |
218850_s_at |
1.446018887 |
0.023303493 |
2451 / 12428 |
MSPI0406S00175023 |
1.13051494 |
5.26E-05 |
NM_001098426 |
SMARCD2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2 |
chr17q23-q24 |
0.241432929 |
0.002557563 |
201827_at |
1.380291621 |
3.03E-06 |
698 / 12428 |
MSPI0406S00819275 |
1.504715315 |
3.59E-24 |
NM_012154 |
EIF2C2 |
Eukaryotic translation initiation factor 2C, 2 |
chr8q24 |
0.235116703 |
0.003333209 |
213310_at |
1.307458219 |
0.010861589 |
2095 / 12428 |
MSPI0406S00446999 |
1.389904445 |
5.01E-06 |
NM_002167 |
ID3 |
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein |
chr1p36.13-p36.12 |
0.230177792 |
0.004081106 |
207826_s_at |
4.283329371 |
6.19E-08 |
504 / 12428 |
MSPI0406S00020688 |
0.774845681 |
8.02E-11 |
NM_000077 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) |
chr9p21 |
0.228757874 |
0.004322401 |
209644_x_at |
1.723245148 |
0.000479606 |
1243 / 12428 |
MSPI0406S00456709 |
0.535208968 |
0.000779916 |
NM_003288 |
TPD52L2 |
tumor protein D52-like 2 |
chr20q13.2-q13.3 |
0.22777089 |
0.00449759 |
201379_s_at |
1.673195631 |
2.93E-05 |
885 / 12428 |
MSPI0406S00939698 |
0.886207548 |
2.94E-10 |
NM_025149 |
ACSF2 |
acyl-CoA synthetase family member 2 |
chr17q21.33 |
0.22240168 |
0.00556696 |
218844_at |
1.388572647 |
0.000573519 |
1282 / 12428 |
MSPI0406S00813773 |
1.156716803 |
5.66E-12 |
NM_000521 |
HEXB |
hexosaminidase B (beta polypeptide) |
chr5q13 |
0.220856507 |
0.00591419 |
201944_at |
1.746546276 |
8.11E-12 |
250 / 12428 |
MSPI0406S00273755 |
0.639588041 |
2.36E-11 |
NM_005319 |
HIST1H1C |
histone cluster 1, H1c |
chr6p21.3 |
0.219388747 |
0.006261789 |
209398_at |
2.04080405 |
0.000537886 |
1262 / 12428 |
MSPI0406S00313168 |
1.837618294 |
6.53E-11 |
NM_001142546 |
LUZP1 |
leucine zipper protein 1 |
chr1p36 |
0.214622458 |
0.007519494 |
221831_at |
1.656359523 |
0.001132072 |
1407 / 12428 |
MSPI0406S00020371 |
0.416538753 |
0.000917125 |
NM_001031714 |
INF2 |
inverted formin, FH2 and WH2 domain containing |
chr14q32.33 |
0.21429007 |
0.00761504 |
218144_s_at |
1.22201382 |
0.0276256 |
2564 / 12428 |
MSPI0406S00696642 |
0.811587417 |
1.01E-09 |
NM_017807 |
OSGEP |
O-sialoglycoprotein endopeptidase |
chr14q11.2 |
0.213650909 |
0.007801802 |
209450_at |
1.226304616 |
0.010063488 |
2056 / 12428 |
MSPI0406S00667526 |
0.769502026 |
0.000326212 |
NM_030797 |
FAM49A |
family with sequence similarity 49, member A |
chr2p24.2 |
0.213518283 |
0.00784106 |
209683_at |
4.755367787 |
1.99E-18 |
95 / 12428 |
MSPI0406S00095620 |
0.289166466 |
0.0036918 |
NM_003521 |
HIST1H2BM |
histone cluster 1, H2bm |
chr6p22-p21.3 |
0.21243609 |
0.008168001 |
208515_at |
1.393025165 |
0.005815752 |
1871 / 12428 |
MSPI0406S00314135 |
0.701377659 |
1.17E-06 |
NM_000594 |
TNF |
tumor necrosis factor (TNF superfamily, member 2) |
chr6p21.3 |
0.211551256 |
0.008444235 |
207113_s_at |
1.311036679 |
0.038541828 |
2779 / 12428 |
MSPI0406S00315947 |
2.765630758 |
1.79E-46 |
NM_001005862 |
ERBB2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
chr17q11.2-q12|17q21.1 |
0.211404057 |
0.008490982 |
216836_s_at |
1.43364855 |
0.011573742 |
2120 / 12428 |
MSPI0406S00805393 |
0.358992892 |
0.030593062 |
NM_012135 |
FAM50B |
family with sequence similarity 50, member B |
chr6p25-pter |
0.207153823 |
0.009943399 |
205775_at |
1.313117497 |
0.014959849 |
2234 / 12428 |
MSPI0406S00305367 |
0.645381603 |
0.000923222 |
NM_004813 |
PEX16 |
peroxisomal biogenesis factor 16 |
chr11p11.2 |
0.206745161 |
0.010093977 |
49878_at |
1.17167416 |
0.003922244 |
1718 / 12428 |
MSPI0406S00562783 |
1.932339879 |
2.67E-22 |
NM_001894 |
CSNK1E |
casein kinase 1, epsilon |
chr22q13.1 |
0.206589081 |
0.010152015 |
202332_at |
1.297767357 |
0.018118575 |
2330 / 12428 |
MSPI0406S00970221 |
1.677622928 |
1.29E-07 |
NM_003906 |
MCM3AP |
minichromosome maintenance complex component 3 associated protein |
chr21q22.3 |
0.205946721 |
0.010393985 |
215582_x_at |
1.202414991 |
0.020091231 |
2374 / 12428 |
MSPI0406S00953548 |
1.431235158 |
2.25E-10 |
NM_013401 |
RAB3IL1 |
RAB3A interacting protein (rabin3)-like 1 |
chr11q12-q13.1 |
0.203755005 |
0.011258252 |
219579_at |
1.212573589 |
0.049750563 |
2974 / 12428 |
MSPI0406S00567424 |
1.735863604 |
8.55E-18 |
NM_004533 |
MYBPC2 |
myosin binding protein C, fast type |
chr19q13.33 |
0.203629483 |
0.011309609 |
206394_at |
1.893012816 |
0.002874995 |
1612 / 12428 |
MSPI0406S00902859 |
0.644298638 |
1.28E-08 |
NM_001066 |
TNFRSF1B |
tumor necrosis factor receptor superfamily, member 1B |
chr1p36.3-p36.2 |
0.203347008 |
0.011425936 |
203508_at |
1.616522449 |
0.011742296 |
2127 / 12428 |
MSPI0406S00011871 |
0.318001131 |
0.001402174 |
NM_001018078 |
FPGS |
folylpolyglutamate synthase |
chr9q34.1 |
0.196828914 |
0.014418459 |
202945_at |
1.424250004 |
0.000239375 |
1129 / 12428 |
MSPI0406S00484872 |
1.574719014 |
2.73E-10 |
NM_000116 |
TAZ |
tafazzin |
chrXq28 |
0.196675304 |
0.014496551 |
37278_at |
1.200708107 |
0.012315914 |
2151 / 12428 |
MSPI0406S01020170 |
0.817358362 |
8.75E-06 |
NM_005475 |
SH2B3 |
SH2B adaptor protein 3 |
chr12q24 |
0.196470394 |
0.014601296 |
203320_at |
1.310307143 |
0.037438006 |
2759 / 12428 |
MSPI0406S00628445 |
1.040524911 |
8.26E-18 |
NM_001040455 |
SIDT2 |
SID1 transmembrane family, member 2 |
chr11q23.3 |
0.192942184 |
0.016511285 |
56256_at |
1.35448564 |
0.001274546 |
1431 / 12428 |
MSPI0406S00587902 |
0.135615433 |
0.033429236 |
NM_173354 |
SIK1 |
salt-inducible kinase 1 |
chr21q22.3 |
0.187324762 |
0.020000862 |
208078_s_at |
2.183198977 |
0.002000165 |
1524 / 12428 |
MSPI0406S00950474 |
1.920576503 |
9.02E-22 |
NM_002528 |
NTHL1 |
nth endonuclease III-like 1 (E. coli) |
chr16p13.3 |
0.186475322 |
0.020580485 |
209731_at |
1.327875294 |
0.017048523 |
2298 / 12428 |
MSPI0406S00736133 |
0.891917693 |
2.84E-10 |
NM_031310 |
PLVAP |
plasmalemma vesicle associated protein |
chr19p13.2 |
0.185876323 |
0.020997884 |
221529_s_at |
1.84368721 |
0.004935926 |
1797 / 12428 |
MSPI0406S00878837 |
0.262320647 |
0.000644182 |
NM_013449 |
BAZ2A |
bromodomain adjacent to zinc finger domain, 2A |
chr12q24.3-qter |
0.184208137 |
0.022199029 |
201354_s_at |
1.690105904 |
1.67E-05 |
835 / 12428 |
MSPI0406S00615771 |
0.673145895 |
3.11E-14 |
NM_002574 |
PRDX1 |
peroxiredoxin 1 |
chr1p34.1 |
0.183893962 |
0.022431745 |
208680_at |
2.0365508 |
3.01E-08 |
474 / 12428 |
MSPI0406S00034956 |
0.798139131 |
0.000547815 |
NM_021813 |
BACH2 |
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
chr6q15 |
0.183885154 |
0.022438299 |
221234_s_at |
4.223062857 |
7.31E-16 |
132 / 12428 |
MSPI0406S00331128 |
0.577268988 |
0.038563175 |
NM_004440 |
EPHA7 |
EPH receptor A7 |
chr6q16.1 |
0.183120038 |
0.023013982 |
206852_at |
2.286603813 |
0.000665911 |
1304 / 12428 |
MSPI0406S00331432 |
0.650586726 |
1.49E-06 |
NM_017999 |
RNF31 |
ring finger protein 31 |
chr14q11.2 |
0.182865436 |
0.023208344 |
220788_s_at |
1.230987018 |
0.031332914 |
2638 / 12428 |
MSPI0406S00669481 |
0.303620512 |
0.013129252 |
NM_002118 |
HLA-DMB |
major histocompatibility complex, class II, DM beta |
chr6p21.3 |
0.181686857 |
0.024126553 |
203932_at |
4.800992389 |
1.50E-23 |
61 / 12428 |
MSPI0406S00316958 |
0.171606264 |
0.03638297 |
NM_006889 |
CD86 |
CD86 molecule |
chr3q21 |
0.181116026 |
0.024582374 |
210895_s_at |
1.522006567 |
0.017517246 |
2312 / 12428 |
MSPI0406S00192518 |
2.328456983 |
6.05E-30 |
NM_002526 |
NT5E |
5'-nucleotidase, ecto (CD73) |
chr6q14-q21 |
0.17782233 |
0.027359289 |
203939_at |
3.048756469 |
5.93E-05 |
969 / 12428 |
MSPI0406S00329870 |
0.636229752 |
2.20E-08 |
NM_006703 |
NUDT3 |
nudix (nucleoside diphosphate linked moiety X)-type motif 3 |
chr6p21.2 |
0.170469435 |
0.034538217 |
221579_s_at |
1.30863779 |
0.000557071 |
1275 / 12428 |
MSPI0406S00318277 |
1.103693991 |
7.85E-06 |
NR_024448 |
LOC91316 |
glucuronidase, beta/ immunoglobulin lambda-like polypeptide 1 pseudogene |
chr22q11.23 |
0.169942434 |
0.035108917 |
213502_x_at |
1.391887789 |
0.017982179 |
2327 / 12428 |
MSPI0406S00960029 |
0.667382628 |
3.69E-17 |
NM_000993 |
RPL31 |
ribosomal protein L31 |
chr2q11.2 |
0.166463662 |
0.03907955 |
221593_s_at |
1.334545612 |
0.005138094 |
1821 / 12428 |
MSPI0406S00121365 |
0.571797519 |
0.001673437 |
NM_003900 |
SQSTM1 |
sequestosome 1 |
chr5q35 |
0.161954946 |
0.044781471 |
201471_s_at |
1.243822834 |
0.005189052 |
1824 / 12428 |
MSPI0406S00302042 |
1.128336905 |
6.69E-12 |
NM_001025108 |
AFF3 |
AF4/FMR2 family, member 3 |
chr2q11.2-q12 |
0.160053943 |
0.047385679 |
205735_s_at |
1.49535095 |
0.024169462 |
2472 / 12428 |
MSPI0406S00120890 |
2.733149169 |
6.60E-28 |
NM_152288 |
ORAI3 |
ORAI calcium release-activated calcium modulator 3 |
chr16p11.2 |
0.159817909 |
0.047717653 |
221864_at |
1.335819229 |
0.005724588 |
1866 / 12428 |
MSPI0406S00755297 |
0.328251624 |
0.016790111 |
NM_001114634 |
PLAG1 |
pleiomorphic adenoma gene 1 |
chr8q12 |
0.159039942 |
0.048825567 |
205372_at |
1.713550325 |
0.006084846 |
1882 / 12428 |
MSPI0406S00429545 |
0.499564444 |
1.64E-05 |
NM_021008 |
DEAF1 |
deformed epidermal autoregulatory factor 1 (Drosophila) |
chr11p15.5 |
0.158696892 |
0.049320859 |
209407_s_at |
1.28918836 |
0.022552313 |
2439 / 12428 |
MSPI0406S00548885 |
1.373425653 |
7.96E-29 |